Suzanne Vanhauwaert
Overview
Explore the profile of Suzanne Vanhauwaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
938
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohib O, Vanhauwaert S, De Boeck L, Claes K, Janssens P
Kidney Int
. 2024 Jul;
106(2):323-324.
PMID: 39032973
No abstract available.
2.
Decaesteker B, Louwagie A, Loontiens S, De Vloed F, Bekaert S, Roels J, et al.
Nat Commun
. 2023 Mar;
14(1):1267.
PMID: 36882421
The pediatric extra-cranial tumor neuroblastoma displays a low mutational burden while recurrent copy number alterations are present in most high-risk cases. Here, we identify SOX11 as a dependency transcription factor...
3.
Zanotti S, Decaesteker B, Vanhauwaert S, De Wilde B, De Vos W, Speleman F
Br J Cancer
. 2022 Feb;
126(11):1529-1538.
PMID: 35197583
Neuroblastoma is a tumour that arises from the sympathoadrenal lineage occurring predominantly in children younger than five years. About half of the patients are diagnosed with high-risk tumours and undergo...
4.
Zanotti S, Vanhauwaert S, Van Neste C, Olexiouk V, Van Laere J, Verschuuren M, et al.
Sci Rep
. 2021 Jul;
11(1):14454.
PMID: 34262099
MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of...
5.
Mus L, Van Haver S, Popovic M, Trypsteen W, Lefever S, Zeltner N, et al.
Genes Chromosomes Cancer
. 2020 Dec;
60(4):272-281.
PMID: 33336840
Human embryonic stem cells (hESCs) and embryonal tumors share a number of common features, including a compromised G1/S checkpoint. Consequently, these rapidly dividing hESCs and cancer cells undergo elevated levels...
6.
Loontiens S, Dolens A, Strubbe S, Van de Walle I, Moore F, Depestel L, et al.
Front Cell Dev Biol
. 2020 Nov;
8:599472.
PMID: 33251223
Transcriptional control of hematopoiesis involves complex regulatory networks and functional perturbations in one of these components often results in malignancies. Loss-of-function mutations in , encoding a presumed epigenetic regulator, have...
7.
Loontiens S, Vanhauwaert S, Depestel L, Dewyn G, Van Loocke W, Moore F, et al.
Leukemia
. 2020 Jun;
34(12):3398-3403.
PMID: 32591643
No abstract available.
8.
Vanhauwaert S, Decaesteker B, De Brouwer S, Leonelli C, Durinck K, Mestdagh P, et al.
Sci Rep
. 2019 Jun;
9(1):8360.
PMID: 31164657
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
9.
Loontiens S, Depestel L, Vanhauwaert S, Dewyn G, Gistelinck C, Verboom K, et al.
BMC Genomics
. 2019 Mar;
20(1):228.
PMID: 30894119
Background: Transgenic zebrafish lines with the expression of a fluorescent reporter under the control of a cell-type specific promoter, enable transcriptome analysis of FACS sorted cell populations. RNA quality and...
10.
Claeys S, Denecker G, Durinck K, Decaesteker B, Mus L, Loontiens S, et al.
Oncogene
. 2018 Dec;
38(15):2690-2705.
PMID: 30538293
ALK mutations occur in 10% of primary neuroblastomas and represent a major target for precision treatment. In combination with MYCN amplification, ALK mutations infer an ultra-high-risk phenotype resulting in very...